Hipsc-cms - OmicsDI

Show results for

Unknown (572)
Genomics (177)
Transcriptomics (122)
Proteomics (23)
Metabolomics (3)
Other (2)
Methylation profiling (1)

Organisms

Homo sapiens (122)
Schizosaccharomyces pombe (13)
Oryza sativa Indica Group (13)
Sinorhizobium meliloti BL225C (13)
Sus scrofa domesticus (13)
Ostreococcus tauri (13)
Saccharomyces cerevisiae (13)
Staphylococcus aureus (13)
Rattus norvegicus (13)
Escherichia coli (13)
Candida albicans (13)
Cyanophora paradoxa (13)
Entamoeba histolytica (13)
Physcomitrium patens (13)
Methylohalobius crimeensis 10Ki (13)
Homo sapiens (13)
Lotus japonicus (13)
Shigella flexneri (13)
Ctenopharyngodon idella (13)
Danio rerio (13)
Allexis (13)
Shigella (13)
Pseudomonas putida KT2440 (13)
Helicobacter pylori 26695 (13)
Streptococcus dysgalactiae subsp. equisimilis SK1249 (13)
Zea mays (13)
Mus musculus (10)
Rattus norvegicus (3)
Homo sapiens/Rattus norvegicus xenograft (1)
Sus scrofa (1)

Organisms

Homo sapiens (136)
Mus musculus (7)
Rattus norvegicus (2)
Sus scrofa (1)

Repository

ENA (168)
geo (122)
pride (13)
biostudies-arrayexpress (10)
MassIVE (8)
LINCS (3)
MetaboLights (3)
iProX (1)
jPOST (1)

Tissue

Heart (7)
Stem cell (5)
Cell culture (5)
Regular ventricular cardiac myocyte (2)
Regular cardiac myocyte (1)
Pluripotent stem cell (1)
Cardiac muscle cell (1)

Disease

Heart failure (1)

Technology Type

Mass Spectrometry (13)
Shotgun proteomics (6)
Mass spectrometry (2)
Gel-based experiment (2)
Bottom-up proteomics (2)
PCR (1)
RNA-seq (1)
DNA sequencing (1)
Fluorescence intensity (1)
Mass spectrometry assay (1)
Data-independent acquisition (1)
Data-dependent acquisition (1)
Top-down proteomics (1)

Instrument Platform

LTQ Orbitrap Elite (3)
Orbitrap Exploris 480 (2)
Liquid Chromatography MS - negative - reverse phase (2)
Illumina NovaSeq X (1)
Illumina NovaSeq 6000 (1)
Orbitrap Fusion Tribrid (1)
NanoACQUITY UPLC (1)
Impact (1)
Impact II (1)
Q Exactive HF (1)
TimsTOF Pro (1)
Liquid Chromatography MS – positive - reverse phase (1)
Liquid Chromatography MS – negative - hilic (1)
Gas Chromatography MS - positive (1)
Liquid Chromatography MS - alternating - reverse phase (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2025 (26)
2023 (22)
2026 (21)
2024 (21)
2022 (20)
2021 (15)
2020 (8)
2016 (7)
2014 (7)
2019 (6)
2018 (5)
2015 (2)

CHEBI ID

CHEBI:94302 (1)
CHEBI:2666 (1)
CHEBI:39548 (1)
CHEBI:6375 (1)
CHEBI:3127 (1)
CHEBI:38940 (1)
CHEBI:7772 (1)
CHEBI:46195 (1)

Metabolite Name

Sunitinib (1)

First Public Date

2024 (27)
2025 (26)
2026 (24)
2022 (23)
2023 (22)
2021 (14)
2020 (11)
2019 (7)
2016 (5)
2018 (3)
2017 (3)
2014 (3)

Study type

Transcription profiling by array (4)
RNA-seq of coding RNA (2)
Other (1)
DNA-seq (1)
RNA-seq of total RNA (1)
RNA-seq of non coding RNA (1)

Release Date

2022 (76)
2023 (74)
2021 (73)
2024 (65)
2020 (62)
2025 (60)
2019 (43)
2018 (37)
2017 (28)
2016 (22)
2026 (13)
2014 (13)
2015 (11)
2013 (2)
2012 (1)
2011 (1)

Lab affiliation

Institute of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany (1)
Murdoch Children's Research Institute, Melbourne, Australia (1)
ITQB-NOVA, Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Av. Da República, 2780-157 Oeiras, Portugal;iBET, Instituto de Biologia Experimental e Tecnológica, Apartado 12, 2780-901, Oeiras , Portugal (1)
Dept. Cell Biology and Molecular Medicince, Rutgers-New Jersey Mediccal School, Newark NJ (1)
Otto Krayer Professor Department of Systems Biology Head of the Harvard Program in Therapeutic Sciences Harvard Medical School 200 Longwood Avenue, WAB440 Boston, MA 02115 (1)
Bioanalytics, Department of Clinical Chemistry, University Medical Center Goettingen (1)
Head Proteomics Group, Leiden University Medical Center, Center for Proteomics and Metabolomics, PO Box 9600, Postal zone P1-Q, 2300 RC Leiden, The Netherlands (1)
Laboratory for Functional Genome Analysis (LAFUGA), Gene Center, LMU Munich, 81377 Munich, Germany (1)
Core Facility Proteomics, Department of Clinical Chemistry, University Medical Center Göttingen, Germany (1)
Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada (1)
King’s British Heart Foundation Centre of Research Excellence, King's College London, United Kingdom (1)
University of Wisconsin-Madison (1)
University of Liverpool (1)

Previous page
1 / 90
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 90
Next page

Sort by:

Relevance

Page size

Transcriptome analysis of hiPSC-CMs carrying FLNC mutations

PRJNA1082894 | ENA

Transcriptome analysis of hiPSC-CMs carrying MYPN mutations

PRJNA1308050 | ENA

Bulk RNAseq analysis of hypertrophic cardiomyopathy (HCM) hiPSC-derived cardiomyocytes (hiPSC-CMs) and the isogenic control

PRJNA814293 | ENA

Transcriptome alterations of hiPSC-CMs after alcohol treatment, alcohol and losartan co-treatment

PRJNA802832 | ENA

RNA Expression Profiling of Human iPSC-Derived Cardiomyocytes in a Cardiac Hypertrophy Model [miRNA expression]

Cardiac hypertrophy is an independent risk factor for cardiovascular disease and heart failure. There is increasing evidence that microRNAs (miRNAs) play an important role in the regulation of messenger RNA (mRNA) and the pathogenesis of various cardiovascular diseases. However, the ability to compr...

ORGANISM(S): Homo sapiens

2014-10-03 | E-GEOD-60292 | biostudies-arrayexpress

microRNA profile expression analysis of Human Induced Pluripotent Stem Cell-derived cardiomyocytes (hiPSC-CMs)

PRJNA438878 | ENA

Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as an In Vitro Model for Coxsackievirus B3-Induced Myocarditis and Antiviral Drug Screening Platform

ABSTRACT Background: Viral myocarditis is a life-threatening illness that may lead to heart failure or cardiac arrhythmias. This study examined whether human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) could be used to model the pathogenic processes of coxsackievirus-induced vi...

ORGANISM(S): Homo sapiens

2014-05-19 | E-GEOD-57781 | biostudies-arrayexpress

RNA Expression Profiling of Human iPSC-Derived Cardiomyocytes in a Cardiac Hypertrophy Model [mRNA expression]

ORGANISM(S): Homo sapiens

2014-10-03 | E-GEOD-60291 | biostudies-arrayexpress

Altered drug response of recovered human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) from cryopreservation

PRJNA609933 | ENA

RNA-seq in healthy and SQT1 hiPSC-CMs upon manipulation of miR-365

PRJNA770438 | ENA